Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC)
Clinical trial NCT02667574 · COMPLETED
Trial details
- NCT number
- NCT02667574
- Sponsor
- University Hospital, Lille
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-18
- Primary completion
- 2020-07-15
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.